U.S. market Closed. Opens in 16 hours 9 minutes

PMCB | PharmaCyte Biotech, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-302015-04-302014-04-302013-04-302012-04-302011-04-302010-04-302009-04-302008-04-302007-04-302006-04-302005-04-302004-04-302003-04-302002-04-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A12.16K66.56K126.00K262.93K653.13K1.19M1.17M537.04K86.37K2.38KN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A9.62K19.38K32.10K228.66K427.41K266.20K171.01KN/A41.40K780.00N/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.54K47.17K93.89K34.27K225.72K923.75K998.65KN/A44.97K1.60KN/AN/A
Operating Expenses8.52M6.46M4.39M3.62M3.83M4.10M6.98M4.44M6.07M13.70M18.98M1.69M2.00M482.25K2.14M6.27M4.67M4.61M7.87M4.21M1.72M32.13K29.85K
Selling, General & Admin2.12M5.99M3.70M2.71M3.53M3.64M4.98M3.26M4.67M10.22M18.98M1.69M2.00M473.05K1.65M5.79M4.26M4.47M7.75M3.10M313.94K32.13KN/A
Research & Development407.43K468.54K690.94K916.25K301.22K460.05K2.00M1.18M1.41M3.48MN/AN/AN/A9.21K492.46K473.51K412.88K133.84K119.01K1.11M1.41MN/AN/A
Other Operating Expenses6.00M202.00K-4.28K-1.19K-40.0033.40KN/AN/AN/AN/AN/AN/AN/AN/A-1.00N/AN/AN/AN/AN/AN/AN/A29.85K
Operating Income-8.52M-6.46M-4.39M-3.62M-3.83M-4.10M-6.98M-4.44M-6.07M-13.70M-18.98M-1.68M-1.95M-388.36K-2.11M-6.04M-3.75M-3.61M-7.34M-4.16M-1.72M-32.13K-29.85K
Other Expenses / Income-8.72M202.00K152.85K71.75K-493.0033.40K152.59K-1.54K9.35K2.84M-8.27M86.26K291.12K-837.69K-3.59M12.99K-65.99K6.08K-1.70M15.29KN/AN/AN/A
Before Tax Income-17.24M-4.32M-4.24M-3.55M-3.83M-4.07M-6.83M-4.44M-6.06M-10.85M-27.25M-1.60MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-6.52M-1.94M-153.36K3.05K453.00-33.40KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-17.24M-4.32M-4.09M-3.55M-3.83M-4.07M-6.83M-4.44M-6.06M-10.85M-27.25M-1.60M-1.90M-1.40M-5.99M-6.04M-3.79M-3.61M-9.39M-4.28M-1.72M-32.13K-29.85K
Interest ExpensesN/AN/A509.003.05K453.00N/AN/AN/AN/AN/A21.05K154.42K241.25K171.66K292.56K27.18KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding9.58M19.49M15.52M1.45M903.81K733.40K646.08K563.82K752.40M704.33M583.22M440.95M374.76M350.34M351.31M201.63M167.93M162.42M136.67M103.85M89.72M88.00M88.00M
Diluted Shares Outstanding9.58M19.49M15.52M1.45M903.81K733.40K646.08K563.82K752.40M704.33M583.22M440.95M374.76M350.34M351.31M227.95M167.93M162.42M136.67M103.85M89.72M88.00M88.00M
EBITDA-8.52M-4.32M-4.24M-3.62M-3.83M-4.10M-6.83M-4.44M-6.07M-13.20M-24.87M-1.44M-1.63M-1.19M-5.58M-5.99M-3.79M-3.61M-9.38M-4.25M-1.72M-32.13K-29.85K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-11,872.42%-2,454.11%-940.79%-2,123.92%-916.45%-318.13%-308.89%-1,747.52%-4,924.67%-72,375.79%0.00%0.00%
EBIT-23.76M-6.25M-4.24M-3.55M-3.83M-4.10M-6.83M-4.44M-6.06M-10.85M-27.23M-1.44M-1.66M-1.23M-5.70M-6.01M-3.79M-3.61M-9.39M-4.28M-1.72M-32.13K-29.85K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-11,872.42%-2,491.16%-973.08%-2,167.62%-920.86%-318.66%-309.00%-1,747.61%-4,951.60%-72,375.79%0.00%0.00%
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-302015-04-302014-04-302013-04-302012-04-302011-04-302010-04-302009-04-302008-04-302007-04-302006-04-302005-04-302004-04-302003-04-302002-04-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙